Jose Luciano Nepomuceno-Silva

Dr. Jose Luciano Nepomuceno-Silva


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2012 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
PDF file
GSGuilherme Rodrigo Reis Monteiro dos Santos
Guilherme Rodrigo Reis Monteiro dos Santos
JNJose Luciano Nepomuceno-Silva
Jose Luciano Nepomuceno-Silva
LMLuiz Dione Barbosa de Melo
Luiz Dione Barbosa de Melo
JMJosé Roberto Meyer-Fernandes
José Roberto Meyer-Fernandes
DSDidier Salmon
Didier Salmon
ULUlisses G. Lopes
Ulisses G. Lopes

13 July 2023 in Viruses
Verified
Journal Article
Open access
PDF file
GSGraziele F. Sousa
Graziele F. Sousa
RCRaphael M. Carpes
Raphael M. Carpes
CSCarina A. O. Silva
Carina A. O. Silva
MPMarcela Espindola Palmeira Pereira
Marcela Espindola Palmeira Pereira
ASAmanda C. V. F. Silva
Amanda C. V. F. Silva
CBCintia Monteiro De Barros
Cintia Monteiro De Barros
COVID-19 has infected humans worldwide, causing millions of deaths or prolonged symptoms in survivors. The transient or persistent symptoms after SARS-CoV-2 infection have been defined as post-COVID-19 conditions (PCC). We conducted a study of 151 Brazilian PCC patients to analyze symptoms and immunoglobulin profiles, taking into account sex, vaccination, hospitalization, and age. Fatigue and myalgia were the most common symptoms, and lack of vaccination, hospitalization, and neuropsychiatric and metabolic comorbidities were relevant to the development of PCC. Analysis of serological immunoglobulins showed that IgA was higher in PCC patients, especially in the adult and elderly groups. Also, non-hospitalized and hospitalized PCC patients produced high and similar levels of IgA. Our results indicated that the detection of IgA antibodies against SARS-CoV-2 during the course of the disease could be associated with the development of PCC and may be an immunological signature to predict prolonged symptoms in COVID-19 patients.

15 December 2022 in PeerJ
Verified
Journal Article
Open access
PDF file
GSGraziele Fonseca de Sousa
Graziele Fonseca de Sousa
TNThuany da Silva Nogueira
Thuany da Silva Nogueira
LSLana Soares de Sales
Lana Soares de Sales
FMFernanda Ferreira Maissner
Fernanda Ferreira Maissner
OOOdara Araújo de Oliveira
Odara Araújo de Oliveira
Cintia de BarrosCintia de Barros
Cintia de Barros
Objective: To analyze the long-term dynamics of antibodies against SARS-CoV-2 and understand the impact of age, gender, and viral load on patients’ immunological response.Methods: Serum samples were obtained from 231 COVID-19 positive patients from Macaé, in Rio de Janeiro state, in Brazil, from June 2020 until January 2021. The production of IgA, IgM, IgG, and IgE against S glycoprotein was analyzed using the S-UFRJ assay, taking into account the age, gender, and viral load.Results: Analysis of antibody production over 7 months revealed that IgA positivity gradually decreased after the first month. Additionally, the highest percentage of IgM positivity occurred in the first month (97% of patients), and declined after this period, while IgG positivity remained homogeneous for all 7 months. The same analysis for IgE revealed that almost all samples were negative. The comparison of antibody production between genders showed no significant difference. Regarding the age factor and antibody production, patients aged ≥60 years produced almost twice more IgA than younger ones (17–39 years old). Finally, a relationship between viral load and antibody production was observed only for older patients.Conclusions: Our work provides an overview of long-term production of antibodies against SARS-CoV-2, suggesting prolonged production of IgA and IgM antibodies for 3 months and continued IgG production for over 7 months. In addition, it identified a correlation between viral load and IgM titers in the older group and, finally, different IgA production between the age groups.

1 January 2022 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
APAllan P. B. Pozzobon
Allan P. B. Pozzobon
APAna C. Petry
Ana C. Petry
CZCarla Zilberberg
Carla Zilberberg
CBCintia Monteiro De Barros
Cintia Monteiro De Barros
JNJose Luciano Nepomuceno-Silva
Jose Luciano Nepomuceno-Silva
RFRODRIGO NUNES FONSECA
RODRIGO NUNES FONSECA
Since the first reported case of COVID-19 in Brazil, the public and private educational system started to close. Up to November 2020, scientific discussions about the return of schooling activities have been rarely performed by the national scientific community and police-makers. The great delay of school returning in Brazil contrasts with successful international strategies of school reopening worldwide and seems counterintuitive with the reopening of non-essential activities. Here, important issues to be considered before and during school reopening are reviewed and discussed. COVID-19 testing is essential to avoid disease spreading, but high cost of individual RT-qPCRs impairs an extensive testing strategy for school returning. To reduce costs and increase the speed of diagnosis, we tested the efficiency of a pooled-sample PCR strategy in a cohort of the educational staff in the city of Macaé/RJ, finding five asymptomatic individuals (0,66%) among the 754 people tested. Thus, a polled-sample PCR testing strategy of the educational staff might prevent infection spreading in schools at a reasonable cost. We discuss how our test strategy could be coupled with internationally recognized safety rules to allow for a safe school return and how countries from different world regions are dealing with educational activities during COVID-19 pandemic.

8 April 2021 in Parasitology
Verified
Journal Article
Closed access
PDF file
JPJuliana Figueiredo Peixoto
Juliana Figueiredo Peixoto
DSDaniele Graças dos Santos
Daniele Graças dos Santos
LRLupis Ribeiro
Lupis Ribeiro
VOVitor Silva Cândido de Oliveira
Vitor Silva Cândido de Oliveira
RNRodrigo Nunes-Da-Fonseca
Rodrigo Nunes-Da-Fonseca
JNJose Luciano Nepomuceno-Silva
Jose Luciano Nepomuceno-Silva
Trichomonas vaginalisis a parasite of the human urogenital tract and the causative agent of trichomoniasis, a sexually transmitted disease of worldwide importance. This parasite is usually found as a motile flagellated trophozoite. However, when subjected to stressful microenvironmental conditions,T. vaginalistrophozoites can differentiate into peculiar cyst-like stages, which exhibit notable physiological resistance to unfavourable conditions. Although well documented in morphological and proteomic terms, patterns of gene expression changes involved in the cellular differentiation into cyst-like stages are mostly unknown. The real-time reverse transcription polymerase chain reaction (RT-qPCR) is recognized as a sensitive and accurate method for quantification of gene expression, providing fluorescence-based data that are proportional to the amount of a target RNA. However, the reliability of relative expression studies depends on the validation of suitable reference genes, which RNAs exhibit a minimum of variation between tested conditions. Here, we attempt to determine suitable reference genes to be used as controls of invariant expression during cold-inducedin vitrodifferentiation ofT. vaginalistrophozoites into cyst-like forms. Furthermore, we reveal that the mRNA from the meiotic recombinase Dmc1 is upregulated during this process, indicating that cryptic sexual events may take place in cyst-like stages ofT. vaginalis.

28 March 2022 in ChemistrySelect
Verified
Journal Article
Closed access
LCLeandro Lara de Carvalho
Leandro Lara de Carvalho
RPRaynná Bittencourt Pena
Raynná Bittencourt Pena
NRNelilma Correia Romeiro
Nelilma Correia Romeiro
JNJose Luciano Nepomuceno-Silva
Jose Luciano Nepomuceno-Silva